Avalo Therapeutics, Inc. ( AVTX) - Stock Earnings
AVTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
AVTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -13.7 million USD | 59000 USD |
| 2026Q1 | -19.6 million USD | — USD |
| 2026Q2 | -36.4 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AVTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -31.5 million USD | 1.9 million USD |
| 2024 | -35.1 million USD | 441000 USD |
| 2025 | -78.3 million USD | 59000 USD |
| 2026 Est. | — | — |
AVTX
Price: $13.24
52 week price:
Earnings Per Share: -4.41 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 45800
Market Capitalization: 714.4 million